Abstract
A 14-year-old boy was diagnosed with mixed phenotype acute leukemia and underwent 28 months of chemotherapy with vincristine and methotrexate. Early in his chemotherapy treatment, he developed hyperalgesia of his feet and ankles, particularly on the left side, believed to be due to the vincristine. Despite medical treatment, he continued to have hyperalgesia and increasing left foot deformity and pain that markedly affected his walking. He presented for orthopaedic evaluation at the end of his chemotherapy and had foot deformities that were corrected surgically with substantial improvement in his foot position and walking ability. He remains in remission for his leukemia. The effects of chemotherapy-induced peripheral neuropathy on the lower extremities are reviewed.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: JBJS Journal of Orthopaedics for Physician Assistants
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
